tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Exelixis (GB:0IJO)
LSE:0IJO
UK Market
0IJO
Exelixis
RESEARCH TOOLSreports
Advertisement

Exelixis (0IJO) Stock News & Sentiment

Compare
1 Followers
Exelixis’s Strategic Positioning and Market Prospects Justify Buy Rating Amid RCC Treatment Dynamics
Premium
Ratings
Exelixis’s Strategic Positioning and Market Prospects Justify Buy Rating Amid RCC Treatment Dynamics
2d ago
EXEL
Buy Rating Affirmed for Exelixis: Promising Phase 3 Trial Results and Favorable Valuation Despite Safety Concerns
Premium
Ratings
Buy Rating Affirmed for Exelixis: Promising Phase 3 Trial Results and Favorable Valuation Despite Safety Concerns
3d ago
EXEL
Apple, MARA, Exelixis, Strategy, Dell: Trending by Analysts
Premium
Weekend Updates
Apple, MARA, Exelixis, Strategy, Dell: Trending by Analysts
5d ago
AAPL
DELL
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
Premium
Ratings
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
10d ago
EXEL
Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
Premium
Ratings
Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
10d ago
EXEL
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
Premium
Ratings
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
15d ago
EXEL
Exelixis Hold Rating: Modest Sales Forecasts and Competitive Challenges Amid Upcoming STELLAR-303 Data
Premium
Ratings
Exelixis Hold Rating: Modest Sales Forecasts and Competitive Challenges Amid Upcoming STELLAR-303 Data
16d ago
EXEL
More GB:0IJO News >

0IJO News on the Web

Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks
Bullish
Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
Neutral
Why Exelixis (EXEL) is Poised to Beat Earnings Estimates Again
Zacks
Bullish
Here's Why Exelixis (EXEL) is a Strong Value Stock
Zacks
Neutral
Apple, MARA, Exelixis, Strategy, Dell: Trending by Analysts
TipRanks News
Neutral
RBC Capital Reaffirms Their Hold Rating on Exelixis (EXEL)
TipRanks News
Neutral
Stocks making the biggest moves midday: Apple, Cleveland-Cliffs, Oracle, KLA, Tempus AI and more
CNBC
Neutral
Exelixis Reports Zanzalintinib-Atezolizumab Combo Reduces Risk of Death by 20% in Metastatic Colorectal Cancer: Phase 3 STELLAR-303 Results Presented at ESMO 2025
Market Chameleon
Neutral

News Score - Last 7 Days

Positive
GB:0IJO
Sector Average
Media Buzz
This Week5 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0IJO’s Media Buzz Sentiment?
5 articles about GB:0IJO were published this week. In an average week, 3.25 articles are published.
    What is GB:0IJO’s weekly average amount of articles?
    In an average week, 3.25 articles about GB:0IJO are published.
      What is GB:0IJO’s News Sentiment?
      100% of articles about GB:0IJO were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        RNAAvidity Biosciences
        UHSUniversal Health
        HCAHCA Healthcare
        SLPSimulations Plus
        BBIOBridgeBio Pharma
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing